Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review

Managing the Economic Challenges in the Treatment of Heart Failure

Highly Selective Inhibition of Myosin Motors Provides the Basis of Potential Therapeutic Application

Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension

Inhibition of Smooth Muscle Myosin as a Novel Therapeutic Target for Hypertension

The Direct Smooth Muscle Myosin Inhibitor, CK-2125927, Represents a Novel Therapeutic Mechanism of Bronchodilation

The Direct Smooth Muscle Myosin Inhibitor, CK-2018571, Represents a Novel Therapeutic Mechanism for Bronchodilation

The Small Molecule Smooth Muscle Myosin Inhibitor, CK-2018571, Selectively Inhibits ATP Hydrolysis and Relaxes Smooth Muscle in vitro

Inhibition of Smooth Muscle Myosin, a Novel Therapeutic Approach for Pulmonary Hypertension

A Direct Inhibitor of Smooth Muscle Myosin as a Novel Therapeutic Approach for the Treatment of Systemic Hypertension.